日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The evolution of centriole degradation in mouse sperm

小鼠精子中心粒降解的演变

Sushil Khanal, Ankit Jaiswal, Rajanikanth Chowdanayaka, Nahshon Puente, Katerina Turner, Kebron Yeshitela Assefa, Mohamad Nawras, Ezekiel David Back, Abigail Royfman, James P Burkett, Soon Hon Cheong, Heidi S Fisher, Puneet Sindhwani, John Gray, Nallur Basappa Ramachandra, Tomer Avidor-Reiss

Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions

处方尼马替韦-利托那韦:如何识别和处理药物相互作用

Marzolini, Catia; Kuritzkes, Daniel R; Marra, Fiona; Boyle, Alison; Gibbons, Sara; Flexner, Charles; Pozniak, Anton; Boffito, Marta; Waters, Laura; Burger, David; Back, David; Khoo, Saye

Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

关于COVID-19抗病毒药物尼马替利韦/利托那韦(Paxlovid)与合并用药之间药物相互作用的管理建议

Marzolini, Catia; Kuritzkes, Daniel R; Marra, Fiona; Boyle, Alison; Gibbons, Sara; Flexner, Charles; Pozniak, Anton; Boffito, Marta; Waters, Laura; Burger, David; Back, David J; Khoo, Saye

The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review

盆腔放射治疗中肠道微生物群与胃肠道毒性:一项临床综述

Oh, Byeongsang; Eade, Thomas; Lamoury, Gillian; Carroll, Susan; Morgia, Marita; Kneebone, Andrew; Hruby, George; Stevens, Mark; Boyle, Frances; Clarke, Stephen; Corless, Brian; Molloy, Mark; Rosenthal, David; Back, Michael

The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?

肠道微生物组与癌症免疫疗法:我们能否将肠道微生物组用作癌症免疫疗法临床反应的预测生物标志物?

Oh, Byeongsang; Boyle, Frances; Pavlakis, Nick; Clarke, Stephen; Eade, Thomas; Hruby, George; Lamoury, Gillian; Carroll, Susan; Morgia, Marita; Kneebone, Andrew; Stevens, Mark; Liu, Wen; Corless, Brian; Molloy, Mark; Kong, Benjamin; Libermann, Towia; Rosenthal, David; Back, Michael

Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review

化疗中肠道微生物群的新证据:临床综述

Oh, Byeongsang; Boyle, Frances; Pavlakis, Nick; Clarke, Stephen; Guminski, Alex; Eade, Thomas; Lamoury, Gillian; Carroll, Susan; Morgia, Marita; Kneebone, Andrew; Hruby, George; Stevens, Mark; Liu, Wen; Corless, Brian; Molloy, Mark; Libermann, Towia; Rosenthal, David; Back, Michael

Plasma and intracellular (peripheral blood mononuclear cells) pharmacokinetics of once-daily raltegravir (800 milligrams) in HIV-infected patients

HIV 感染者每日一次服用雷替拉韦(800 毫克)的血浆和细胞内(外周血单核细胞)药代动力学

José Moltó, Marta Valle, David Back, Samandhy Cedeño, Victoria Watson, Neill Liptrott, Deirdre Egan, Cristina Miranda, Manuel J Barbanoj, Bonaventura Clotet

Plasma and intracellular pharmacokinetics of darunavir/ritonavir once daily and raltegravir once and twice daily in HIV-infected individuals

HIV 感染者每日一次服用达芦那韦/利托那韦以及每日一次和两次服用雷替拉韦的血浆和细胞内药代动力学

Akil Jackson, Victoria Watson, David Back, Saye Khoo, Neill Liptrott, Deidre Egan, Keerti Gedela, Chris Higgs, Riaz Abbas, Brian Gazzard, Marta Boffito

Effect of prototypical inducers on ligand activated nuclear receptor regulated drug disposition genes in rodent hepatic and intestinal cells

原型诱导剂对啮齿动物肝肠细胞中配体激活核受体调节药物处置基因的影响

Philip Martin, Robert Riley, Paul Thompson, Dominic Williams, David Back, Andrew Owen